Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PHAR · against 557 other Healthcare companies listed in US-listed
Ranked #161 of 558 · scores higher than 71% of peers
Bars: peers in each 10-point band of the profitability score28 peers with a profitability score of 50–59, including PHAR · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | PHAR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | 15.5% | -7.0% | 84% | 33% | |
| Operating marginHigher is better · 479 reported | 6.9% | -2.4% | 64% | 33% | |
| Return on assetsHigher is better · 582 reported | 0.6% | -7.8% | 62% | 33% | |
| Return on equityHigher is better · 531 reported | 3.6% | -19.7% | 68% | Context only | |
| Gross marginHigher is better · 601 reported | 86.5% | 43.9% | 88% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 158 | 18.5B USD | 60 | 54 | |
| 161 | 1.6B USD | 59 | 52 | |
| 161 | 78.1B USD | 59 | 60 | |
| 161 | 9.2B USD | 59 | 47 | |
| 161 | 915M USD | 59 | 57 | |
| 161 | 1.3B USD | 59 | 48 | |
| 166 | 35.0B USD | 58 | 52 | |
| 166 | 969M USD | 58 | 54 | |
| 168 | 11.6B USD | 57 | 58 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score